BDBM767401 1-[[3-[[4-[4-[2-allyl-1-[6-(1- hydroxy-1-methyl-ethyl)-2-pyridyl]- 3-oxo-pyrazolo[3,4-d]pyrimidin-6- yl]amino]phenyl]piperazin-1- yl]methyl]-4-fluoro-phenyl]methyl]- 5-fluoro-quinazoline-2,4-dione::US20250270212, Compound 34

SMILES C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(Cc5cc(Cn6c(=O)[nH]c(=O)c7c(F)cccc76)ccc5F)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 767401   

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767401(1-[[3-[[4-[4-[2-allyl-1-[6-(1- hydroxy-1-methyl-et...)
Affinity DataEC50: <10nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent